Literatur
- 1
Ahlgren J D.
Chemotherapy for pancreatic carcinoma.
Cancer.
1996;
78
653-663
- 2
Bajetta E, DiBartolomeo M, Stani S C. et al .
Chemoradiotherapy as preoperative
treatment in locally advanced unresectable pancreatic cancer patients: Results
of a feasibility study.
Int J Radiat Oncol Biol Phys.
1999;
45
285-289
- 3
Beger H G, Gansauge F, Büchler M W, Link K H.
Intraarterial
adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic
cancer: significant reduction in occurrence of liver metastasis.
World
J Surg.
1999;
23
946-949
- 4
Bissig K D, Mayerle J, Lerch M M, Friess H, Büchler M W.
Der unklare Pankreastumor: Wann stenten,
wann operieren.
Dtsch Med Wochenschr.
2001;
126
(Suppl 2)
107-114
- 5
Burris H A, Moore M J, Andersen J.
Improvements
in survival and clinical benefit with gemcitabine as first-line
therapy for patients with advanced pancreas cancer: a randomized
trial.
J Clin Oncol.
1997;
15
2043-2413
- 6
Büchler P, Reber H A, Büchler M C. et al .
Therapy for pancreatic
cancer with a recombinant humanized Anti-HER2 Antibody (Herceptin).
J
Gastrointest Surg.
2001;
5
139-146
- 7
DiCarlo V, Zerbi A, Balzano G, Corso V.
Pylorus-preserving pancreaticoduodenectomy
versus conventional whipple operation.
World J Surg.
1999;
23
920-925
- 8
DiPetrillo T, Safran H.
Paclitaxel and concurrent
radiation for locally advanced pancreatic cancer.
Proc
Am Soc Clin Oncol.
2000;
19
1152
- 9
Evans D B.
Preoperative
chemoradiation for resectable and locally advanced adenocarcinoma
of the pancreas.
J Gastrointest Surg.
2001;
5
2-5
- 10
Gastrointestinal Tumor
Study Group .
Further evidence of effective adjuvant combined
radiation and chemotherapy following curative resection for pancreas
cancer.
Cancer.
1987;
59
2006-2010
- 11
Ghaneh P, Salvin J, Sutton R, Hartley M, Neoptolemos J P.
Adjuvant therapy in pancreatic cancer.
World
J Gastroenterol.
2001;
7
482-489
- 12
Gouma D J, van Dijkum E J, van Geenen R C, van Gulik T M, Obertop H.
Are there indications
for palliative resection in pancreatic cancer?.
World J
Surg.
1999;
23
954-959
- 13
Hotz H G, Reber H A, Hotz B. et al .
Angiogenesis Inhibitor TNP-470 reduces human
pancreatic cancer growth.
J Gastrointest Surg.
2001;
5
131-138
- 14
Huang J J, Yeo C J, Sohn T A. et al .
Quality of life and outcomes
after pancreaticoduodenectomy.
Ann Surg.
2000;
231
890-898
- 15
Klinkenbijl J, Jeekel J, Sahmound T. et al .
Adjuvant radiotherapy and 5-fluorouracil
after curative resection of cancer of the pancreas and periampullary
region.
Ann Surg.
1999;
230
776-784
- 16
Kubuschok B, Schmits R, Hartmann F. et al .
The use of spontaneous EBV - lymphoblastoid
cell lines genetically modified to express tumor antigen as cancer
vaccines: Mutated p21 ras oncogene in pancreatic carcinoma as a model.
Hum
Gene Ther.
2002;
13
815-827
- 17
Lüttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Klöppel G.
The retroperitoneal
resection margin and vessel involvement are important factors determining
survival after pancreaticoduodenectomy for ductal adenocarcinoma
of the head of the pancreas.
Virchows Arch Path.
1998;
433
237-242
- 18
Neoptolemos J P, Kerr D J, Beger H G. et al .
ESPAC-1 trial
progress report: The European randomized adjuvant study comparing
radiochemotherapy, 6 months chemotherapy and combined therapy versus
observation in pancreatic cancer.
Digestion.
1997;
58
570-577
- 19
Pingpank J F, Hoffmann J P, Ross E A. et al .
Effect of preoperative chemoradiotherapy
on surgical margin status of resected adenocarcinoma of the head of
the pancreas.
J Gastrointest Surg.
2001;
5
121-130
- 20
Shibata C, Kobari M, Tsuchiya T. et al .
Pancreatectomy combined with superior mesenteric-portal
vein resection for adenocarcinoma in pancreas.
World Journal
of Surgery.
2001;
25
1002-1005
- 21
Schulz H J, Braunschweig U, Schmidt H.
Endoskopische
Therapie der Gallengangsstenose.
Dtsch Med Wochenschr.
2001;
126
(Suppl 2)
136-140
- 22
Wenger F A, Jacobi C A, Haubold K, Zieren H U, Muller J M.
Gastrointestinale Lebensqualität
nach Duodenopancreatectomie beim Pankreaskarzinom. Vorläufige
Ergebnisse einer prospektiv-randomisierten Studie: PD vs PPPD.
Chirurg.
1999;
70
1454-1459
- 23
Willett C G, Lewandrowski K, Warshaw A L. et al .
Resection margins in carcinoma
of the head of the pancreas: Implications for radiation therapy.
Ann of
Surg.
1993;
217
144-148
Prof. Dr. med. Martin K. Schilling
Abteilung für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätskliniken
des Saarlandes
66424 Homburg/Saar
Telefon: 06841/1622605
Fax: 06841/1622697
eMail: martin.schilling@uniklinik-saarland.de